Australia's CSL Withdraws Seasonal Trivalent Flu Vaccine For Children Under 5

PERTH, Australia - Australia's CSL Biotherapies has ceased distribution of its pediatric seasonal influenza vaccine following a significant increase in reports of fever and febrile convulsions in children under 5 years of age shortly after receiving CSL's Fluvax Junior vaccine compared to previous seasons, CSL announced June 1